Skip to content

Drug interactions

Mavacamten + Verapamil

Severity: Major

Mavacamten and Verapamil: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs reduce cardiac contractility, so combining them may precipitate reduced ejection fraction and heart failure. Verapamil also inhibits CYP3A4 and may raise mavacamten exposure.

What this interaction means in plain words

Mavacamten and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Mavacamten belongs to Cardiovascular; Verapamil belongs to Cardiovascular.

Evidence level: High

Why it happens

Additive negative inotropic effects, together with CYP3A4 inhibition by verapamil increasing mavacamten levels.

What to do

Monitor LVEF and clinical status closely when starting or changing verapamil or mavacamten, and follow echocardiographic dose-titration guidance. Interrupt mavacamten if heart failure symptoms or reduced LVEF occur.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mavacamten and Verapamil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mavacamten with Verapamil?

MediHelp rates the interaction as major. Mavacamten and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs reduce cardiac contractility, so combining them may precipitate reduced ejection fraction and heart failure. Verapamil also inhibits CYP3A4 and may raise mavacamten exposure.

How serious is the interaction between Mavacamten and Verapamil?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor LVEF and clinical status closely when starting or changing verapamil or mavacamten, and follow echocardiographic dose-titration guidance. Interrupt mavacamten if heart failure symptoms or reduced LVEF occur.

What other medicines interact with Verapamil?

MediHelp also lists interactions of Verapamil with, for example, Dofetilide, Flibanserin, Lomitapide. The full list is on the Verapamil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in